How Cost-effective is 'No Smoking Day'?
Overview
Authors
Affiliations
Objective: To obtain a more rigorous estimate of the cost-effectiveness of No Smoking Day (NSD), an annual UK-wide campaign to encourage smokers to quit, than has been possible hitherto.
Design: Comparison of reported quit attempts in the month following NSD for three consecutive years with adjacent months using repeated national surveys of quit attempts.
Setting: England.
Participants: A total of 1309 adults who had smoked in the past year who responded to the surveys in the month following NSD (April 2007-2009) and a comparison group of 2672 adults who smoked in the past year who responded to the survey in the two adjacent months (March and May 2007-2009).
Main Outcome Measures: The number of additional smokers who quit permanently in response to NSD was estimated from the survey results. The incremental cost-effectiveness ratio (ICER) was calculated by combining this estimate with established estimates of life years gained and the known costs of NSD.
Results: The rate of quit attempts was 2.8 percentage points higher in the months following NSD (120/1309) compared with the adjacent months (170/2672; 95% CI 0.99% to 4.62%), leading to an estimated additional 0.07% of the 8.5 million smokers in England quitting permanently in response to NSD. The cost of NSD per smoker was £ 0.088. The discounted life years gained per smoker in the modal age group 35-44 years was 0.00107, resulting in an ICER of £ 82.24 (95% CI 49.7 to 231.6). ICER estimates for other age groups were similar.
Conclusions: NSD emerges as an extremely cost-effective public health intervention.
Kuhn J, Olie V, Grave C, Le Strat Y, Bonaldi C, Joly P Clin Epidemiol. 2024; 16:605-616.
PMID: 39262929 PMC: 11389704. DOI: 10.2147/CLEP.S440815.
The Impact of the Media Portrayal of Coeliac Disease: A Qualitative Study.
Verma S, Bains M Cureus. 2022; 14(12):e32444.
PMID: 36523855 PMC: 9744388. DOI: 10.7759/cureus.32444.
Effectiveness of 'Mois sans tabac 2016': A French social marketing campaign against smoking.
Guignard R, Andler R, Richard J, Pasquereau A, Quatremere G, Arwidson P Tob Induc Dis. 2021; 19:60.
PMID: 34305506 PMC: 8288465. DOI: 10.18332/tid/139028.
Evaluation of the London Smoking Cessation Transformation Programme: a time-series analysis.
Jackson S, Beard E, West R, Brown J Addiction. 2020; 116(6):1558-1568.
PMID: 33283375 PMC: 8247014. DOI: 10.1111/add.15367.
van der Vliet N, Suijkerbuijk A, de Blaeij A, de Wit G, van Gils P, Staatsen B Int J Environ Res Public Health. 2020; 17(6).
PMID: 32213919 PMC: 7142580. DOI: 10.3390/ijerph17062160.